Virtu Financial’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-23,129
| Closed | -$120K | – | 2219 |
|
|
2024
Q3 | $120K | Buy |
+23,129
| New | +$120K | 0.01% | 876 |
|
|
2024
Q1 | – | Sell |
-24,946
| Closed | -$219K | – | 2252 |
|
|
2023
Q4 | $219K | Sell |
24,946
-11,431
| -31% | -$100K | 0.02% | 764 |
|
|
2023
Q3 | $417K | Buy |
36,377
+23,788
| +189% | +$273K | 0.04% | 396 |
|
|
2023
Q2 | $319K | Buy |
+12,589
| New | +$319K | 0.02% | 590 |
|
|
2020
Q4 | – | Sell |
-27,010
| Closed | -$679K | – | 1870 |
|
|
2020
Q3 | $679K | Buy |
+27,010
| New | +$679K | 0.12% | 205 |
|